Efficacy and Safety of Relacorilant for the Treatment of Patients With Cushing’s Syndrome (GRACE): A Multicentre, Phase 3, Double-Blind, Placebo-Controlled, Randomised-Withdrawal Study
Published: The Lancet Diabetes & Endocrinology, 2026
Authors: Pivonello R, Arnaldi G, Auchus RJ, et al.
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.